SOMNORIL Trademark

Trademark Overview


On Friday, June 14, 2024, a trademark application was filed for SOMNORIL with the United States Patent and Trademark Office. The USPTO has given the SOMNORIL trademark a serial number of 98601881. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Tuesday, January 7, 2025. This trademark is owned by Gateway Health Alliances, Inc.. The SOMNORIL trademark is filed in the Pharmaceutical Products category with the following description:

An ingredient in dietary and nutritional supplements.
somnoril

General Information


Serial Number98601881
Word MarkSOMNORIL
Filing DateFriday, June 14, 2024
Status641 - NON-FINAL ACTION - MAILED
Status DateTuesday, January 7, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesAn ingredient in dietary and nutritional supplements.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, June 14, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGateway Health Alliances, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressFairfield, CA 94534

Trademark Events


Event DateEvent Description
Friday, June 14, 2024NEW APPLICATION ENTERED
Sunday, January 5, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, January 6, 2025ASSIGNED TO EXAMINER
Tuesday, January 7, 2025NON-FINAL ACTION E-MAILED
Tuesday, January 7, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, January 7, 2025NON-FINAL ACTION WRITTEN